Hypoxia induced with cobalt chloride could protect mesenchymal stem cellsfrom harsh environment: An in vitro study
Publish place: 1st International Iranian Tissue Engineering and Regenerative Medicine Congress (ITERM2018)
Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 377
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ITERMED01_199
تاریخ نمایه سازی: 7 مرداد 1398
Abstract:
IntroductionApplication of stem cells encountered some problems such as low cell viability and apoptosis induction following transplantation in body due to harsh environments. Pre-conditioning of the cells with cytotoxicfactors might improvetheir efficiencybut their mechanism is not clear.ObjectivesOurstudy investigated how Cobalt(II) chlorideexerts its protective effects on MSCs after preconditioning.MethodsBone marrow mesenchymal stem cells were cultured with0 (control),5, 10, 20, 50, 70, 90, 100, 120, 150, 200Μmof Cobalt chloride for 6, 12, 24 and 48 hours, followed by treatment with lethal dose of CoCl2(300 μM) for 24 hours. Cells viability was determined by trypan blue. Inaddition, TUNEL assay was performedto study cell apoptosis.ResultsOur findings indicated that preconditioningaffected themesenchymal stem cells dose dependently, as120μMafter 6,and 20μMafter 12 and 24hsignificantlyincreasedcell viability compared to the control group. But, longer exposure time did not changerate of viable cells significantlycompared to control group (P > 0.05). Moreover, treatment of 5μMCoCl2significantly decreased apoptosisrate after 48 hours(P < 0.05), although this decrease in apoptosis wasnot remarkable in other groups.ConclusionCell therapy needs novel strategiesfor improvement ofits efficacy after transplantation.Our findings suggestedthat preconditioningof the cells with hypoxia induced by CoCl2 can improve the cellsurvival and decreasedapoptosis. Preconditioning might providecellularresistance and pave the pathway for application of cell therapy in further clinical trials more confidently
Keywords:
Authors
Marziyeh Pooladi
Anatomical Sciences Department, Medicine faculty, Hamadan University of Medical Sciences, Hamadan, Iran
Iraj Amiri
Anatomical Sciences Department, Medicine faculty, Hamadan University of Medical Sciences, Hamadan, Iran
Zohreh Alizadeh
Anatomical Sciences Department, Medicine faculty, Hamadan University of Medical Sciences, Hamadan, Iran
Amaneh Mohammadi Roushandeh
Medical Biotechnology Research Center, Paramedicine Faculty, Guilan University of Medical Sciences, Rasht, Iran